PVI
MTCR

Pura Vida Investments’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Pura Vida Investments’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-198,230
Closed -$99K – 274
2022
Q2 		$99K Hold
198,230
– – 0.01% 200
2022
Q1 		$121K Buy
198,230
+1,100
+0.6% +$577 ﹤0.01% 219
2021
Q4 		$133K Buy
+197,130
New +$352K ﹤0.01% 225

Other funds holding MTCR

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Pura Vida Investments's MTCR Position: Q3 2022 in Review

Pura Vida Investments sold out of Metacrine, Inc. Common Stock (MTCR) in Q3 2022, closing a stake of 198,230 shares — an estimated $99K sold.

Pura Vida Investments first reported a position in MTCR in Q4 2021 and held it in 3 quarters. The position peaked at $133K in Q4 2021. 27 funds tracked by Wall St. Rank hold MTCR as of Q3 2022.

  • Pura Vida Investments reported no remaining Metacrine, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Pura Vida Investments sold 198,230 Metacrine, Inc. Common Stock shares in Q3 2022, an estimated $99K.
  • Pura Vida Investments first reported a position in Metacrine, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Pura Vida Investments's Metacrine, Inc. Common Stock position peaked at $133K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.